Loading patent…
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite Pierre Et Marie Curie (UPMC), Universite Paris Diderot—Paris 7, Universite Paris Descartes, Assistance Publique-Hopitaux de Paris
InventorsSantos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
Estimating the term…
The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
A method for treating cancer in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a soluble peptide comprising the amino acid sequence:
A soluble peptide of formula (I):
(canceled)
A soluble peptide of formula (III):
(canceled)
Dependencies are inferred from the claim text.